In vitro, CUR suppressed the growth of tumor cells, enhanced gemcitabine-induced apoptosis, and inhibited the constitutive NF-κB activation of several pancreatic cancer cell lines [124,125]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.